CapsoVision

CapsoVision OpEx/Revenue

The Operating Expenses to Revenue Ratio of CapsoVision (CV) as of Nov 4, 2026 is 185.62 %. In the previous year, Operating Expenses to Revenue Ratio was 164.40 % — a change of 12.91% (higher).

OpEx/Revenue

185.62 %

YoY

12.91%

Last updated:

Operating Expenses to Revenue Ratio of CapsoVision is 2025 185.62 % . Operating Expenses to Revenue Ratio of CapsoVision was 2024 164.40 % . It decreases by 12.91% higher compared to the previous year.

The CapsoVision OpEx/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OpEx/Revenue
Date
OpEx/Revenue
Jan 1, 2023
115.91 USD
Jan 1, 2024
164.40 USD
Jan 1, 2025
185.62 USD
The CapsoVision OpEx/Revenue history
YEAROpEx/RevenueYoY
185.62 %+12.91%
164.40 %+41.83%
115.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CapsoVision Stock analysis

What does CapsoVision do? CapsoVision, Inc. generates revenue through its flagship product CapsoCam Plus, a small bowel capsule endoscope featuring a 360 panoramic lateral view that enhances imaging capabilities compared to traditional end-facing cameras. The company also offers CapsoCloud, a cloud-based software application for secure clinical data management, and a capsule collection kit designed for sanitary, single-use patient handling of the CapsoCam Plus device. These products are sold to healthcare providers and medical facilities seeking advanced gastrointestinal diagnostic solutions. The CapsoCam Plus system targets medical professionals requiring superior imaging for small bowel examinations, while CapsoCloud caters to clinics needing efficient data handling. The capsule collection kit serves as an essential accessory for patient use, ensuring proper capsule handling. All products are marketed directly to healthcare institutions and clinics specializing in gastrointestinal care. CapsoVision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CapsoVision stock

Operating Expenses to Revenue Ratio of CapsoVision is 185.62 % in 2025.

Operating Expenses to Revenue Ratio of CapsoVision changed from 164.40 % to 185.62 %, representing a 12.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Expenses to Revenue Ratio CapsoVision since 2006 – with annual values, charts, and detailed analysis.

The OpEx/Revenue ratio measures total operating expenses as a percentage of revenue. Declining ratios suggest improving operational leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Expenses to Revenue Ratio's CapsoVision with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Expenses to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Expenses to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — CapsoVision

All Key Metrics — CapsoVision